MiMedx Group (MDXG) Reports Q4 EPS of 12c, Offers Guidance

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.12, $0.06 better than the analyst estimate of $0.06. Revenue for the quarter came in at $51.8 million versus the consensus estimate of $51.84 million.

GUIDANCE:

MiMedx Group sees FY2016 EPS of $0.33-$0.37, versus the consensus of $0.28. MiMedx Group sees FY2016 revenue of $260-270 million, versus the consensus of $262.44 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Nvidia underperforms peers as report sparks rack delay worries
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge